National Cancer Institute; Notice of Meeting, 74198 [2023-23881]
Download as PDF
74198
Federal Register / Vol. 88, No. 208 / Monday, October 30, 2023 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the Board of Scientific
Counselors, National Cancer Institute.
The meeting will be held as a virtual
meeting and is open to the public as
indicated below. Individuals who plan
to view the virtual meeting and need
special assistance or other reasonable
accommodations to view the meeting,
should notify the Contact Person listed
below in advance of the meeting. The
open session will be videocast and can
be accessed from the NIH Videocast at
the following link: https://
videocast.nih.gov/.
The meeting will be closed to the
public as indicated below in accordance
with the provisions set forth in section
552b(c)(6), title 5 U.S.C., as amended for
the review, discussion, and evaluation
of individual intramural programs and
projects conducted by the National
Cancer Institute, including
consideration of personnel
qualifications and performance, and the
competence of individual investigators,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
khammond on DSKJM1Z7X2PROD with NOTICES
Name of Committee: Board of Scientific
Counselors, National Cancer Institute.
Date: March 4, 2024.
Open: 11:00 a.m. to 11:30 a.m.
Agenda: Remarks from the NCI Director.
Closed: 11:40 a.m. to 4:30 p.m.
Agenda: Personnel qualifications and
performance, and competence of individual
investigators.
Name of Committee: Board of Scientific
Counselors, National Cancer Institute.
Date: March 5, 2024.
Closed: 11:00 a.m. to 1:30 p.m.
Agenda: Personnel qualifications and
performance, and competence of individual
investigators.
Place: National Cancer Institute, 9609
Medical Center Drive, Rockville, MD 20892
(Virtual Meeting).
Contact Person: Brian E. Wojcik, Ph.D.,
Senior Review Administrator, Institute
Review Office, Office of the Director,
National Cancer Institute, National Institutes
of Health, 9609 Medical Center Drive, Room
3W414, Rockville, MD 20850, 240–276–5660,
wojcikb@mail.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
VerDate Sep<11>2014
18:18 Oct 27, 2023
Jkt 262001
Information is also available on the
Institute’s/Center’s home page: https://
deainfo.nci.nih.gov/advisory/bsc/index.htm,
where an agenda and any additional
information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: October 25, 2023.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–23881 Filed 10–27–23; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of General Medical
Sciences; Notice of Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Advisory
General Medical Sciences Council.
The meeting will be held as a virtual
meeting and open to the public. as
indicated below. Individuals who plan
to view the virtual meeting and need
special assistance, such as sign language
interpretation or other reasonable
accommodations, should submit a
request using the following link: https://
www.nigms.nih.gov/Pages/
ContactUs.aspx at least 5 days prior to
the event. The open session will also be
videocast, closed captioned, and can be
accessed from the NIH Videocasting and
Podcasting website (https://
videocast.nih.gov).
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
General Medical Sciences Council.
Date: February 1, 2024.
Open: 9:30 a.m. to 12:30 p.m.
Agenda: For the discussion of program
policies and issues; opening remarks; report
PO 00000
Frm 00057
Fmt 4703
Sfmt 4703
of the Director, NIGMS; and other business
of the Council.
Place: National Institutes of Health,
Natcher Building, 45 Center Drive, Bethesda,
MD 20892 (Virtual Meeting).
Closed: 1:30 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, 45 Center Drive, Bethesda,
MD 20892 (Virtual Meeting).
Contact Person: Erica L. Brown, Ph.D.,
Director, Division of Extramural Activities,
National Institute of General Medical
Sciences, National Institutes of Health,
Natcher Building, Room 2AN24C, Bethesda,
MD 20892, 301–594–4499, erica.brown@
nih.gov.
Members of the public are welcome to
provide written comments by emailing
NIGMS_DEA_Mailbox@nigms.nih.gov at least
3 days in advance of the meeting. The
statement should include the name, address,
telephone number and when applicable, the
business or professional affiliation of the
interested person.
Information is also available on the
Institute’s/Center’s home page: https://
www.nigms.nih.gov/About/Council, where an
agenda and any additional information for
the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance
Program No. 93.859, Biomedical Research
and Research Training, National Institutes of
Health, HHS)
Dated: October 24, 2023.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–23809 Filed 10–27–23; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Amended
Notice of Meeting
Notice is hereby given of a change in
the meeting of the Center for Scientific
Review Special Emphasis Panel, PAR
20–103: Collaborative Program Grant for
Multidisciplinary Teams (RM1),
November 03, 2023, 10:00 a.m. to
November 03, 2023, 06:00 p.m.,
National Institutes of Health, Rockledge
II, 6701 Rockledge Drive, Bethesda, MD
20892 which was published in the
Federal Register on October 05, 2023,
88 FR 69211, Doc 2023–22116.
This meeting is being amended to
change the meeting panel name to PAR
23–077: Collaborative Program Grant for
Multidisciplinary Teams (RM1). The old
name contains an old PAR number: PAR
20–103. The meeting is closed to the
public.
E:\FR\FM\30OCN1.SGM
30OCN1
Agencies
[Federal Register Volume 88, Number 208 (Monday, October 30, 2023)]
[Notices]
[Page 74198]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-23881]
[[Page 74198]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Meeting
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the Board of Scientific
Counselors, National Cancer Institute.
The meeting will be held as a virtual meeting and is open to the
public as indicated below. Individuals who plan to view the virtual
meeting and need special assistance or other reasonable accommodations
to view the meeting, should notify the Contact Person listed below in
advance of the meeting. The open session will be videocast and can be
accessed from the NIH Videocast at the following link: https://videocast.nih.gov/.
The meeting will be closed to the public as indicated below in
accordance with the provisions set forth in section 552b(c)(6), title 5
U.S.C., as amended for the review, discussion, and evaluation of
individual intramural programs and projects conducted by the National
Cancer Institute, including consideration of personnel qualifications
and performance, and the competence of individual investigators, the
disclosure of which would constitute a clearly unwarranted invasion of
personal privacy.
Name of Committee: Board of Scientific Counselors, National
Cancer Institute.
Date: March 4, 2024.
Open: 11:00 a.m. to 11:30 a.m.
Agenda: Remarks from the NCI Director.
Closed: 11:40 a.m. to 4:30 p.m.
Agenda: Personnel qualifications and performance, and competence
of individual investigators.
Name of Committee: Board of Scientific Counselors, National
Cancer Institute.
Date: March 5, 2024.
Closed: 11:00 a.m. to 1:30 p.m.
Agenda: Personnel qualifications and performance, and competence
of individual investigators.
Place: National Cancer Institute, 9609 Medical Center Drive,
Rockville, MD 20892 (Virtual Meeting).
Contact Person: Brian E. Wojcik, Ph.D., Senior Review
Administrator, Institute Review Office, Office of the Director,
National Cancer Institute, National Institutes of Health, 9609
Medical Center Drive, Room 3W414, Rockville, MD 20850, 240-276-5660,
[email protected].
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
Information is also available on the Institute's/Center's home
page: https://deainfo.nci.nih.gov/advisory/bsc/index.htm, where an
agenda and any additional information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS)
Dated: October 25, 2023.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2023-23881 Filed 10-27-23; 8:45 am]
BILLING CODE 4140-01-P